116 results
FWP
VTAK
Catheter Precision Inc.
24 Sep 18
Free writing prospectus
3:02pm
, e.g., an ultrasound. We believe this will allow FDA to evaluate the clinical success of a DABRA atherectomy procedure. At this time, our strategy … atherectomy procedure. At this time, our strategy to collect the data necessary to expand our indications is not yet certain based on numerous factors
8-K
EX-99.1
VTAK
Catheter Precision Inc.
8 Mar 21
Regulation FD Disclosure
4:30pm
PHAROS strategy focused on commercial execution and growing business in a capital-efficient manner post-COVID Large Market Opportunity in PAD An estimated … market with segment revenues projected to be greater than $750 million in 20212 Strategy focused on development of next-generation catheters and clinical
8-K
EX-99.1
VTAK
Catheter Precision Inc.
22 May 20
Ra Medical Systems Announces Pricing of $10.0 Million Public Offering
4:17pm
commercial relaunch strategy.
The securities described above are being offered by Ra Medical pursuant to a registration statement on Form S-1 (File No. 333 … or expressions that concern Ra Medical’s future expectations, strategy, plans or intentions. Forward-looking statements in this press release include
8-K
EX-99.1
VTAK
Catheter Precision Inc.
16 Aug 21
Ra Medical Systems Announces Sale of Pharos Dermatology Business
4:55pm
this transaction is in the best interest of Ra Medical and our shareholders as we intend to maximize value with a strategy that continues to focus … of these words or other similar terms or expressions that concern Ra Medical’s future expectations, strategy, plans or intentions. Forward-looking
8-K
EX-99.1
VTAK
Catheter Precision Inc.
13 May 19
Ra Medical Systems Reports First Quarter 2019 Financial Results
4:15pm
manufacturing process to accommodate catheter production at scale and commenced our new commercial strategy,” said Dean Irwin, CEO of Ra Medical. “We … ” or “continue” or the negative of these words or other similar terms or expressions that concern Ra Medical’s future expectations, strategy, plans or intentions
8-K
EX-99.1
d08vafw
15 Aug 22
Ra Medical Systems Reports Second Quarter 2022 Financial Results
5:49pm
8-K
EX-99.1
o13auerxbyfp l8t
14 Sep 20
Regulation FD Disclosure
8:00am
8-K
EX-99.1
m3drygjegw8dwej1
12 Aug 19
Ra Medical Systems Reports Preliminary Second Quarter 2019 Financial Results
5:12pm
8-K
EX-99.1
hmfhkzz
14 Mar 19
Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results
4:05pm
8-K
EX-99.2
ekkf87
22 May 20
Ra Medical Systems Announces Pricing of $10.0 Million Public Offering
4:17pm
8-K
EX-99.1
pvh7vi 6jl988rn19
29 Apr 20
Ra Medical Systems Appoints Joan Stafslien to its Board of Directors
8:31am
8-K
EX-99.1
4o48h
11 May 21
Ra Medical Systems Reports 2021 First Quarter Financial Results
4:05pm
8-K
EX-99.1
i9netlgy
5 Jan 21
Regulation FD Disclosure
8:15am
8-K
EX-99.1
waptor7lv2 fudslwbvz
12 Nov 20
Ra Medical Systems Reports 2020 Third Quarter Financial Results
4:07pm
8-K
EX-99.1
q5vtn7sqh1p7eokkm
16 May 22
Ra Medical Systems Reports First Quarter 2022 Financial Results
4:28pm
8-K
EX-99.2
zqtet0f8m89 7ge
13 Nov 18
Ra Medical Systems Reports Third Quarter 2018 Results
12:00am
8-K
EX-99.1
hfz7u03n1xxaml
16 Aug 21
Ra Medical Systems Reports 2021 Second Quarter Financial Results
5:05pm
8-K
EX-99.1
v7kt9m
13 May 20
Ra Medical Systems Reports 2020 First Quarter Financial Results
4:13pm
8-K
EX-99.1
azhkgvovm 0x4v3t4e
10 Mar 20
Ra Medical Systems Reports 2019 Fourth Quarter and Full Year Financial Results
4:14pm
8-K
EX-99.1
xyzw88fr
29 Nov 19
Ra Medical Systems Reports Third Quarter 2019 Financial Results
6:02am